---
title: "DEERFIELD PRIVATE DESIGN FUND III, L.P. — Ownership Dossier"
canonical: https://whiteintel.dev/entity/596448ff-eaf9-59b5-a0cf-fe45bd0c0970
json: https://whiteintel.dev/api/public/dossier/596448ff-eaf9-59b5-a0cf-fe45bd0c0970
identifier: sec:0001603333
jurisdiction: US
risk: Low
source: WhiteIntel corporate-ownership graph
---

# DEERFIELD PRIVATE DESIGN FUND III, L.P.

**Type:** Company  
**Jurisdiction:** US  
**Identifier:** `sec:0001603333`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/596448ff-eaf9-59b5-a0cf-fe45bd0c0970  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/596448ff-eaf9-59b5-a0cf-fe45bd0c0970  

## Cross-source identity

The same real-world entity, resolved across sources:

- **Deerfield Private Design Fund III, L.P.** — GLEIF · `lei:549300J7PNJ3QF7GZH92` — https://whiteintel.dev/entity/df50af47-c7e1-537a-aee9-7534ef79fa48

## Ownership & control

### Holdings / subsidiaries

- **FOG PHARMACEUTICALS, INC.** (tenpercentowner) — https://whiteintel.dev/entity/b329372d-d220-55fe-86a9-04133ff86476
- **FOG PHARMACEUTICALS, INC.** (other) — https://whiteintel.dev/entity/b329372d-d220-55fe-86a9-04133ff86476
- **Larimar Therapeutics, Inc.** (director) — https://whiteintel.dev/entity/72e3523f-efab-5ee4-b03e-4139df749767
- **Larimar Therapeutics, Inc.** (tenpercentowner) — https://whiteintel.dev/entity/72e3523f-efab-5ee4-b03e-4139df749767
- **Larimar Therapeutics, Inc.** (other) — https://whiteintel.dev/entity/72e3523f-efab-5ee4-b03e-4139df749767
- **ARS Pharmaceuticals, Inc.** (tenpercentowner) — https://whiteintel.dev/entity/a9c00c55-4330-55f3-a417-febad978a7c8
- **FRACTYL HEALTH, INC.** (other) — https://whiteintel.dev/entity/f48e2075-6673-54c8-9ad0-ee8488117855
- **FRACTYL HEALTH, INC.** (tenpercentowner) — https://whiteintel.dev/entity/f48e2075-6673-54c8-9ad0-ee8488117855
- **ARS Pharmaceuticals, Inc.** (director) — https://whiteintel.dev/entity/a9c00c55-4330-55f3-a417-febad978a7c8
- **ARS Pharmaceuticals, Inc.** (tenpercentownerother) — https://whiteintel.dev/entity/a9c00c55-4330-55f3-a417-febad978a7c8
- **ONCORUS, INC.** (tenpercentownerother) — https://whiteintel.dev/entity/49a765be-476c-53e1-ab95-f16b61b3af27
- **Acutus Medical, Inc.** (tenpercentownerother) — https://whiteintel.dev/entity/772f3e5e-743f-521e-8ae9-602f841e3b2d
- **Acutus Medical, Inc.** (director) — https://whiteintel.dev/entity/772f3e5e-743f-521e-8ae9-602f841e3b2d
- **Larimar Therapeutics, Inc.** (tenpercentownerother) — https://whiteintel.dev/entity/72e3523f-efab-5ee4-b03e-4139df749767
- **ONCORUS, INC.** (director) — https://whiteintel.dev/entity/49a765be-476c-53e1-ab95-f16b61b3af27
- **LUMOS PHARMA, INC.** (tenpercentownerother) — https://whiteintel.dev/entity/64076a09-cab0-5d69-bb5e-15a5eca2d879
- **CalciMedica, Inc.** (tenpercentownerother) — https://whiteintel.dev/entity/c7ed6606-c932-53d3-a1b4-63ef4d5513a2
- **Q32 Bio Inc.** (tenpercentownerother) — https://whiteintel.dev/entity/08894b83-faf4-53f2-980d-374ae48ff38a
- **Q32 Bio Inc.** (director) — https://whiteintel.dev/entity/08894b83-faf4-53f2-980d-374ae48ff38a
- **SHOCKWAVE MEDICAL, INC.** (tenpercentownerother) — https://whiteintel.dev/entity/1badac5e-2472-5645-835b-b5a5aff5d379
- **XERIS PHARMACEUTICALS INC** (tenpercentownerother) — https://whiteintel.dev/entity/3a535122-62e2-50b3-872c-5a949fba4f33
- **ARVINAS, INC.** (tenpercentownerother) — https://whiteintel.dev/entity/c68c871a-7d56-5616-92f8-6e15a2da829d
- **AERIE PHARMACEUTICALS INC** (tenpercentownerother) — https://whiteintel.dev/entity/e07a187d-fd99-5b48-a5d9-f9f42410ccd6
- **RHYTHM PHARMACEUTICALS, INC.** (tenpercentownerother) — https://whiteintel.dev/entity/fa951071-e445-5c3f-9817-53aaddc9e6a0
- **Protara Therapeutics, Inc.** (directorother) — https://whiteintel.dev/entity/d54e2413-cebc-5e01-bc86-3b7d84bd9785
- **AUDENTES THERAPEUTICS, INC.** (tenpercentownerother) — https://whiteintel.dev/entity/b3cefdfe-f536-5019-bb42-7e2793f88657
- **LS22, INC.** (tenpercentownerother) — https://whiteintel.dev/entity/3e598953-a994-5c75-bab0-550d6c26ea32
- **Editas Medicine, Inc.** (tenpercentownerother) — https://whiteintel.dev/entity/ef77060a-ecdc-5822-8634-7ef724c01154
- **AVEXIS, INC.** (tenpercentownerother) — https://whiteintel.dev/entity/6a9d98dd-e10f-5e1a-827f-3b8688801e85
- **CytomX Therapeutics, Inc.** (tenpercentownerother) — https://whiteintel.dev/entity/6548f99c-6754-59ef-a2b1-ed7cd21f6d1b
- **ALIMERA SCIENCES INC** (tenpercentownerother) — https://whiteintel.dev/entity/7d2efdb1-0a0d-5c94-ad59-fe2239278452
- **REGENXBIO Inc.** (tenpercentownerother) — https://whiteintel.dev/entity/52c0a915-b0b6-5f41-87ad-bd1b3f22992a
- **NEOS THERAPEUTICS, INC.** (tenpercentownerother) — https://whiteintel.dev/entity/fd7737cb-d6d9-51da-8a25-e379f1a3890f
- **aTYR PHARMA INC** (tenpercentownerother) — https://whiteintel.dev/entity/7d0875a2-005c-5837-b4fa-bd6cd0d6d971
- **STEADYMED LTD.** (tenpercentownerother) — https://whiteintel.dev/entity/271ae324-cc1a-513a-8726-3c866035edab
- **Protara Therapeutics, Inc.** (tenpercentownerother) — https://whiteintel.dev/entity/d54e2413-cebc-5e01-bc86-3b7d84bd9785
- **Adverum Biotechnologies, Inc.** (tenpercentownerother) — https://whiteintel.dev/entity/2e479e2e-9ea8-5cf7-a7a3-5d423cc5e323

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **DEERFIELD PRIVATE DESIGN FUND III, L.P.**. Human view: https://whiteintel.dev/entity/596448ff-eaf9-59b5-a0cf-fe45bd0c0970 · Structured JSON: https://whiteintel.dev/api/public/dossier/596448ff-eaf9-59b5-a0cf-fe45bd0c0970._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._